nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
|
Öcal, Osman |
|
|
49 |
13 |
p. 4716-4726 |
artikel |
2 |
An encoder-decoder network for direct image reconstruction on sinograms of a long axial field of view PET
|
Ma, Ruiyao |
|
|
49 |
13 |
p. 4464-4477 |
artikel |
3 |
Anti-GD2 antibody for radiopharmaceutical imaging of osteosarcoma
|
Fu, Yingli |
|
|
49 |
13 |
p. 4382-4393 |
artikel |
4 |
Application of artificial intelligence in nuclear medicine and molecular imaging: a review of current status and future perspectives for clinical translation
|
Visvikis, Dimitris |
|
|
49 |
13 |
p. 4452-4463 |
artikel |
5 |
A quantitative in vivo imaging platform for tracking pathological tau depositions and resultant neuronal death in a mouse model
|
Kimura, Taeko |
|
|
49 |
13 |
p. 4298-4311 |
artikel |
6 |
Artificial intelligence guided enhancement of digital PET: scans as fast as CT?
|
Hosch, René |
|
|
49 |
13 |
p. 4503-4515 |
artikel |
7 |
Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [18F]FDG PET/CT imaging: quantitative analysis of [18F]FDG uptake in primary tumors and metastatic lymph nodes
|
Wang, DaQuan |
|
|
49 |
13 |
p. 4692-4704 |
artikel |
8 |
Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy
|
Huang, Wenhui |
|
|
49 |
13 |
p. 4427-4439 |
artikel |
9 |
Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
|
Eertink, Jakoba J. |
|
|
49 |
13 |
p. 4642-4651 |
artikel |
10 |
Correction to: Hetero-bivalent agents targeting FAP and PSMA
|
Boinapally, Srikanth |
|
|
49 |
13 |
p. 4755 |
artikel |
11 |
Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [18F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma
|
Henriksen, Otto M. |
|
|
49 |
13 |
p. 4677-4691 |
artikel |
12 |
EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data
|
van Sluis, Joyce |
|
|
49 |
13 |
p. 4652-4660 |
artikel |
13 |
Feasibility of in vivo CAR T cells tracking using streptavidin–biotin-paired positron emission tomography
|
Pan, Donghui |
|
|
49 |
13 |
p. 4419-4426 |
artikel |
14 |
18F-FDG PET/CT findings of mesenchymal hamartoma of the liver in an adolescent
|
Yu, Congcong |
|
|
49 |
13 |
p. 4748-4749 |
artikel |
15 |
Hetero-bivalent agents targeting FAP and PSMA
|
Boinapally, Srikanth |
|
|
49 |
13 |
p. 4369-4381 |
artikel |
16 |
Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study
|
Pitombeira, Milena Sales |
|
|
49 |
13 |
p. 4551-4566 |
artikel |
17 |
Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment delivery
|
Roosen, Joey |
|
|
49 |
13 |
p. 4705-4715 |
artikel |
18 |
Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment
|
Doering, E. |
|
|
49 |
13 |
p. 4478-4489 |
artikel |
19 |
Long-term test-retest of cerebral [18F]MK-6240 binding and longitudinal evaluation of extracerebral tracer uptake in healthy controls and amnestic MCI patients
|
Vanderlinden, Greet |
|
|
49 |
13 |
p. 4580-4588 |
artikel |
20 |
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease
|
Hartrampf, Philipp E. |
|
|
49 |
13 |
p. 4727-4735 |
artikel |
21 |
Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer’s disease: additional results from the AMBAR study
|
Cuberas-Borrós, Gemma |
|
|
49 |
13 |
p. 4589-4600 |
artikel |
22 |
Noninvasive photoacoustic computed tomography/ultrasound imaging to identify high-risk atherosclerotic plaques
|
Liu, Xuewei |
|
|
49 |
13 |
p. 4601-4615 |
artikel |
23 |
Optical molecular imaging and theranostics in neurological diseases based on aggregation-induced emission luminogens
|
Cen, Peili |
|
|
49 |
13 |
p. 4529-4550 |
artikel |
24 |
PET/NIR-II fluorescence imaging and image-guided surgery of glioblastoma using a folate receptor α-targeted dual-modal nanoprobe
|
Shi, Xiaojing |
|
|
49 |
13 |
p. 4325-4337 |
artikel |
25 |
Pilot study of a novel nanobody 68 Ga-NODAGA-SNA006 for instant PET imaging of CD8+ T cells
|
Wang, Yan |
|
|
49 |
13 |
p. 4394-4405 |
artikel |
26 |
Preclinical and first-in-human evaluation of 18F-labeled D-peptide antagonist for PD-L1 status imaging with PET
|
Zhou, Ming |
|
|
49 |
13 |
p. 4312-4324 |
artikel |
27 |
Preclinical evaluation of [18F]FDG-PET as a biomarker of lymphoid tissue disease and inflammation in Zika virus infection
|
Victorio, Carla Bianca Luena |
|
|
49 |
13 |
p. 4516-4528 |
artikel |
28 |
Presence of non-Newtonian fluid in invasive pulmonary mucinous adenocarcinomas impacts fluorescence during intraoperative molecular imaging of lung cancer
|
Azari, Feredun |
|
|
49 |
13 |
p. 4406-4418 |
artikel |
29 |
Promise of hypoxia-targeted tracers in metastatic lymph node imaging
|
Goel, Shreya |
|
|
49 |
13 |
p. 4293-4297 |
artikel |
30 |
Quantitative evaluation of a deep learning-based framework to generate whole-body attenuation maps using LSO background radiation in long axial FOV PET scanners
|
Sari, Hasan |
|
|
49 |
13 |
p. 4490-4502 |
artikel |
31 |
Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine
|
van der Heide, Circe D. |
|
|
49 |
13 |
p. 4616-4641 |
artikel |
32 |
Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer’s continuum
|
Salvadó, Gemma |
|
|
49 |
13 |
p. 4567-4579 |
artikel |
33 |
Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity
|
Ruigrok, Eline A. M. |
|
|
49 |
13 |
p. 4440-4451 |
artikel |
34 |
The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review
|
Kiamanesh, Zahra |
|
|
49 |
13 |
p. 4661-4676 |
artikel |
35 |
Usefulness of 18F-FPP-RGD2 PET in pathophysiological evaluation of lung fibrosis using a bleomycin-induced rat model
|
Hiroyama, Shuichi |
|
|
49 |
13 |
p. 4358-4368 |
artikel |
36 |
Use of [11C]choline PET/CT for visualization of four hyperactive parathyroid glands in a patient with renal hyperparathyroidism
|
Raitza, Matti |
|
|
49 |
13 |
p. 4750-4751 |
artikel |
37 |
Visualisation of pelvic autonomic nerves using NIR-II fluorescence imaging
|
Qu, Qiaojun |
|
|
49 |
13 |
p. 4752-4754 |
artikel |
38 |
X-ray multiscale 3D neuroimaging to quantify cellular aging and neurodegeneration postmortem in a model of Alzheimer’s disease
|
Barbone, Giacomo E. |
|
|
49 |
13 |
p. 4338-4357 |
artikel |
39 |
[89Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer: first clinical experience from a pilot study including biodistribution and dose estimates
|
Rosar, Florian |
|
|
49 |
13 |
p. 4736-4747 |
artikel |